Other than that, I agree with pretty much everything you just said. One thing to keep in mind when it comes to policy however, is data quality. The vaccine trials were double blind, controlled studies, which are the highest quality of medical study. This is why the short term, vaccine efficacy results were quickly acted on. By necessity, the OP and the studies you linked are retrospective, observational studies which are considerably more difficult to analyze correctly, and usually provide lower confidence results. Which is why the Israel study is so important (they seem to have high data quality) and why we're waiting for so many of these studies to come in before changing public health recommendation.
One concern I do have about the Israeli data is that the paper on waning vaccine efficacy is using de-anonymized data, which means that for privacy and national security reasons, it's more difficult for the scientific community to double check their results.